Fig. 11From: Platelet-derived biomaterial with hyaluronic acid alleviates temporal-mandibular joint osteoarthritis: clinical trial from dish to humanSchematic of therapeutic mechanism action of hPRP/HA therapy in TMJ-OA disease. hPRP (human platelet rich plasma) and HA (hyaluronic acid) ameliorates the bone degradation by upregulation chondrogenic genes in inflammatory (IL-1β and TNF-α) induced TMJ-OA modelBack to article page